Neural tube defect prevalence in california (1990-1994): Eliciting patterns by type of defect and maternal race/ethnicity

Genetic Testing

Volumn 3, Issue 3, 1999, Pages 265-272

  Feuchtbaum, Lisa B ^a   Currier, Robert J ^a   Riggle, Susan ^a   Roberson, Marie ^a   Lorey, Fred W ^a   Cunningham, George C ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANENCEPHALUS; ARTICLE; ASIAN; CAUCASIAN; ENCEPHALOCELE; ETHNIC DIFFERENCE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PREVALENCE; RACE DIFFERENCE; SPINA BIFIDA; UNITED STATES;

ANENCEPHALY; CALIFORNIA; CONTINENTAL POPULATION GROUPS; ENCEPHALOCELE; ETHNIC GROUPS; FEMALE; GENETIC SCREENING; HUMANS; LOGISTIC MODELS; MALE; NEURAL TUBE DEFECTS; ODDS RATIO; PREGNANCY; PREVALENCE; REGISTRIES; SPINAL DYSRAPHISM;

EID: 0032819943     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065799316572     Document Type: Article

References (25)

1. CALIFORNIA VITAL STATISTICS SUMMARIES. (1990-1996). California Department of Health Services.
2. CANFIELD, M.A., ANNEGERS, J.F., BRENDER, J.D., COOPER, S.P., and GREENBERG, F. (1996a). Hispanic origin and neural tube defects in Houston/Harris County, Texas: 1. Descriptive epidemiology. Am. J. Epidemiol. 143, 1-11.
3. CANFIELD, M.A., ANNEGERS, J.F., BRENDER, J.D., COOPER, S.P., and GREENBERG, F. (1996b). Hispanic origin and neural tube defects in Houston/Harris County, Texas: 11. Risk factors. Am. J. Epidemiol. 143, 12-24.
4. CENTERS FOR DISEASE CONTROL. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41, 1-7.
5. CRAGAN, J.D., ROBERTS, H.E., EDMONDS, L.D., and KHOURY, M.J. (1995). Surveillance for Anencephaly and Spina Bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR 44 (SS-4).
6. CUCKLE, W.S., WALD, N.J., and CUCKLE, P.M. (1989). Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985. Prenat. Diagn. 9, 393-400.
7. CZEIZEL, A.E., and DUDAS, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation. N. Engl. J. Med. 327, 1832-1835.
8. DOLK, H., DE WALS, P., GILLEROT, Y., LECHAT, M.F., AYME, S., CORNEL, M., CUSCHIERI, A., GARNE, E., GOUJARD, J., LAURENCE, K.M., et al. (1991). Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology 44, 547-559.
9. EDMONDS, L.D. (1997). State Birth Defects Surveillance Programs Directory. Teratology 56, 63-114.
10. ELWOOD, J.M., LITTLE, J., and ELWOOD, J.H. (1992). Epidemiology and Control of Neural Tube Defects. (Oxford Medical Publications, Oxford University Press, New York).
11. EUROCAT WORKING GROUP. (1991). Prevalence of neural tube defects in 10 regions of Europe and the impact of prenatal diagnosis, 1980-1986. Epidemiology Community Health 45, 52-58.
12. HARRIS, J.A., and SHAW, G.M. (1995). Neural tube defects - why are rates high among populations of Mexican descent? Environ Health Perspect. 103, Suppl 6163-6164.
13. JACOBSEN, P. (1996). Regional variations in neural tube defects and alfa-fetoprotein screening in Denmark 1983-88. Acta Obstet. Gynecol. Scand. 75, 620-623.
14. LARY, J.M., and EDMONDS, L.D. (1996). Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ. 45, 15-26.
15. MONTELEONE-NETO, R., and CASTILLA, E.E. (1994). Apparently normal frequency of congenital anomalies in the highly polluted town of Cubatao, Brazil. Am. J. Med. Genet. 52, 319-323.
16. MOORE, C.A., LI, S., LI, Z., HONG, S.X., GU, H.Q., BERRY, R.J., MULINARE, J., and ERICKSON, J.D. (1997). Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am. J. Med. Genet. 73, 113-118.
17. MULINARE, J., and ERICKSON, J.D. (1997). Prevention of neural tube defects. Teratology 56, 17-18.
18. SAS INSTITUTE, INC. (1990). SAS, version 6.0. Cary, North Carolina.
19. SEVER, L.E. (1982). An epidemiologic study of neural tube defects in Los Angeles County II. Etiologic factors in an area with low prevalence at birth. Teratology 25, 323-334.
20. SHAW, G.M., JENSVOLD, N.G., WASSERMAN, C.R., and LAMMER, E.J. (1994). Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987. Teratology 49, 143-149.
21. SHAW, G.M., SCHAFFER, D., VELIE, E.M., MORLAND, K., and HARRIS, J.A. (1995). Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6, 219-226.
22. SHAW, G.M., VELIE, E.M., and WASSERMAN, C.R. (1997). Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am. J. Public Health 87, 1467-1471.
23. STRASSBURG, M.A., GREENLAND, S., PORTIGAL, L.D., et al. (1983). A population-based case-control study of anencephaly and spina bifida in a low-risk area. Dev. Med. & Child Neurol. 25, 632-641.
24. VELIE, E.M., and SHAW, G.M. (1996). Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am. J. Epidemiol. 144, 473-479.
25. WAITZMAN, N.J., ROMANO, P.S., and SCHEFFLER, R.M. (1994). Estimates of the economic costs of birth defects. Inquiry 31, 188-205.